HL217 (HuniLife)

N/A

Report date: 2024/12/31 17:14:32

Base Information

Drug NameHL217 (HuniLife)
Drug Alias NameHuL217HuL-217HL217 (HuniLife)HL-217 (HuniLife)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAlpha-enolase inhibitors
TargetsAlpha-enolase
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesHuniLife Biotechnology Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A